Lyra Therapeutics's total assets for Q3 2024 were $78.76M, a decrease of -16.73% from the previous quarter. LYRA total liabilities were $58.14M for the fiscal quarter, a -8.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.